Geisinger President and CEO Dr. David T. Feinberg jumps to second on annual most influential list
Recognized for changing the status-quo in health care
Behind U.S. President Donald J. Trump, in the top position, Dr. Feinberg shares the second spot on the list with 11 others who are identified collectively as “disruptors,” a group of healthcare leaders looking to change the status quo of the health industry. He is joined in the group with, among others, Jeff Bezos, chairman and CEO of Amazon; Tim Cook, CEO of Apple; Dr. Marc Harrison, president and CEO of Intermountain Health; and Bernard Tyson, chairman and CEO of Kaiser Permanente.
Now in its 17th year, Modern Healthcare’s annual “100 Most Influential People in Healthcare” list honors and recognizes individuals who have had the most significant impact on the health care industry, as voted on by their peers and the magazine’s senior editors.
Under Dr. Feinberg’s leadership, the Danville-based health system has rolled out programs and services to put the focus on precision medicine and patient care. In May 2018, Dr. Feinberg announced that Geisinger would launch a first-of-its-kind clinical DNA screening program that would make exome sequencing a routine part of patient care. Two months later in July, Dr. Feinberg rolled up his sleeve and became the first patient to participate in the program.
“Understanding our genome’s warning signals will become an essential part of managing our health,” Dr. Feinberg said of the program in July. “Participants can now work with their physicians to deal with what their genome reveals long before they become sick. That might involve making lifestyle changes to reduce their risks or understanding future healthcare needs. This allows us to provide truly anticipatory healthcare, instead of only reacting when it may be too late to change the outcome.”
Along with the clinical DNA program, Geisinger also introduced Fresh Food Farmacy in 2016, which provides free healthy food and education for patients suffering from Type 2 diabetes. The program’s patients have seen success in lowering their hemoglobin A1C and the program is being replicated across the country.
Dr. Feinberg earned his undergraduate degree at the University of California, Berkeley, and graduated with distinction from the University of Health Sciences/Chicago Medical School. He earned a Master’s of Business Administration from Pepperdine University.
This is the fourth time Dr. Feinberg has made Modern Healthcare’s 100 Most Influential list. In addition to this recognition, he recently ranked in the top three of the health care magazine’s “Top 50 Most Influential Physician Executives and Leaders” 2018 list and was named one of the “100 Great leaders in Healthcare” by Becker’s Hospital Review, among other national honors.
The complete list is available here.
About Geisinger
Geisinger is among the nation’s leading providers of value-based care, serving 1.2 million people in urban and rural communities across Pennsylvania. Founded in 1915 by philanthropist Abigail Geisinger, the non-profit system generates $10 billion in annual revenues across 134 care sites - including 10 hospital campuses, and Geisinger Health Plan, with 600,000 members in commercial and government plans. The Geisinger College of Health Sciences educates more than 5,000 medical professionals annually and conducts more than 1,400 clinical research studies. With 26,000 employees, including 1,600 employed physicians, Geisinger is among Pennsylvania’s largest employers with an estimated economic impact of $14 billion to the state’s economy. On March 31, 2024, Geisinger became the first member of Risant Health, a new nonprofit charitable organization created to expand and accelerate value-based care across the country. Learn more at geisinger.org or connect with us on Facebook, Instagram, LinkedIn and X.
